Rep. Tom Price is likely to be grilled in a Wednesday confirmation hearing for his nomination to be Department of Health and Human Services secretary about a new report that he invested in a medical device company just before introducing a bill that would have directly helped the company.
Price bought between $1,001 and $15,000 worth of shares in Zimmer Biomet, according to House records that CNN reviewed. Just days later, the Georgia Republican introduced legislation that would have delayed until 2018 a regulation from the Centers for Medicare and Medicaid Services widely believed to be detrimental to the company.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
Already a member? Log in
